Patents by Inventor Nadir Askenasy

Nadir Askenasy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180208888
    Abstract: The present invention discloses a device and a kit adapted for selection of cells that are resistant to receptor-mediated apoptosis and a method for using the device and kit. The device enables negative selection of mature immune cells which induce graft versus host disease (GvHD) out of a heterogeneous cell population which is introduced into the device. The device enables an efficient cell selection in simplified and cheaper setting by an off the shelf product—a solution that currently do not exist. The present invention further discloses uses for the device.
    Type: Application
    Filed: September 7, 2017
    Publication date: July 26, 2018
    Inventors: Shai Yarkoni, Nadir ASKENASY
  • Patent number: 9783778
    Abstract: The description discloses a device and a kit adapted for selection of cells that are resistant to receptor-mediated apoptosis and a method for using the device and kit. The device enables negative selection of mature immune cells which induce graft versus host disease (GvHD) out of a heterogeneous cell population which is introduced into the device. The device enables an efficient cell selection in simplified and cheaper setting by an off the shelf product—a solution that currently do not exist. The description further discloses uses for the device.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: October 10, 2017
    Assignee: Cellect Biotherapeutics Ltd.
    Inventors: Shai Yarkoni, Nadir Askenasy
  • Patent number: 9624469
    Abstract: An isolated immune regulatory cell having an exogenous cell death-inducing moiety attached to a surface thereof is disclosed herein. Additionally, a molecule comprising a cell death-inducing moiety heterologously attached to an immune regulatory cell-specific binding moiety is disclosed herein. Methods of generating and using same as well as pharmaceutical compositions comprising same are also disclosed.
    Type: Grant
    Filed: July 21, 2011
    Date of Patent: April 18, 2017
    Assignee: Cellect Biotherapeutics Ltd.
    Inventors: Shai Yarkoni, Nadir Askenasy
  • Publication number: 20150044182
    Abstract: The present invention discloses a device and a kit adapted for selection of cells that are resistant to receptor-mediated apoptosis and a method for using the device and kit. The device enables negative selection of mature immune cells which induce graft versus host disease (GvHD) out of a heterogeneous cell population which is introduced into the device. The device enables an efficient cell selection in simplified and cheaper setting by an off the shelf product—a solution that currently do not exist. The present invention further discloses uses for the device.
    Type: Application
    Filed: March 5, 2013
    Publication date: February 12, 2015
    Inventors: Shai Yarkoni, Nadir Askenasy
  • Publication number: 20130287750
    Abstract: A method of selecting stem cells from a heterogeneous population of cells is disclosed. The method comprises contacting the population of cells with an apoptosis inducing agent under conditions which are apoptotic to non-stem cells and non-apoptotic to stem cells, thereby selecting the stem cells from the heterogeneous population of cells. The selected stem cells may then be used for a variety of applications including transplantation and differentiation.
    Type: Application
    Filed: April 15, 2013
    Publication date: October 31, 2013
    Inventor: Nadir ASKENASY
  • Publication number: 20130129771
    Abstract: An isolated immune regulatory cell having an exogenous cell death-inducing moiety attached to a surface thereof is disclosed herein. Additionally, a molecule comprising a cell death-inducing moiety heterologously attached to an immune regulatory cell-specific binding moiety is disclosed herein. Methods of generating and using same as well as pharmaceutical compositions comprising same are also disclosed.
    Type: Application
    Filed: July 21, 2011
    Publication date: May 23, 2013
    Applicant: CELLECT BIOTECHNOLOGY LTD.
    Inventors: Shai Yarkoni, Nadir Askenasy
  • Patent number: 8435786
    Abstract: A method of selecting stem cells from heterogeneous population of cells is disclosed. The method comprises contacting the population of cells with an apoptosis inducing agent under conditions which are apoptotic to non-stem cells and non-apoptotic to stem cells, thereby selecting the stem cells from the heterogeneous population of cells. The selected stem cells may then be used for a variety of applications including transportation and differentiation.
    Type: Grant
    Filed: May 31, 2007
    Date of Patent: May 7, 2013
    Assignee: Cellect Biotechnology Ltd.
    Inventor: Nadir Askenasy
  • Publication number: 20100040582
    Abstract: A method of selecting stem cells from heterogeneous population of cells is disclosed. The method comprises contacting the population of cells with an apoptosis inducing agent under conditions which are apoptotic to non-stem cells and non-apoptotic to stem cells, thereby selecting the stem cells from the heterogeneous population of cells. The selected stem cells may then be used for a variety of applications including transportation and differentiation.
    Type: Application
    Filed: May 31, 2007
    Publication date: February 18, 2010
    Inventor: Nadir Askenasy
  • Patent number: 7138144
    Abstract: A method of inducing tolerance to a transplant transplanted from a donor to a subject is disclosed. The method comprises (a) restricting outflow of a fluid from a portion of the circulatory system of the subject; and (b) administering a dose of bone marrow cells derived from the donor to a body part delimiting said portion of the circulatory system, prior to, concomitantly with or following transplantation of the transplant, thereby inducing tolerance to the transplant in the subject.
    Type: Grant
    Filed: September 9, 2002
    Date of Patent: November 21, 2006
    Inventor: Nadir Askenasy
  • Publication number: 20030064058
    Abstract: A method of inducing tolerance to a transplant transplanted from a donor to a subject is disclosed. The method comprises (a) restricting outflow of a fluid from a portion of the circulatory system of the subject; and (b) administering a dose of bone marrow cells derived from the donor to a body part delimiting said portion of the circulatory system, prior to, concomitantly with or following transplantation of the transplant, thereby inducing tolerance to the transplant in the subject.
    Type: Application
    Filed: September 9, 2002
    Publication date: April 3, 2003
    Inventor: Nadir Askenasy